Table 3.
Association between SSH1 expression in GC and adjacent-to-carcinoma tissues and clinico-pathological features of GC
| Variables | Cancer tissue | Adjacent-to-carcinoma tissue | ||||
|---|---|---|---|---|---|---|
| SSH1(+) | SSH1(−) | P-value | SSH1(+) | SSH1(−) | P-value | |
| Age (years) | 0.311 | 0.722 | ||||
| ≤ 55 | 5 | 16 | 15 | 2 | ||
| >55 | 29 | 50 | 51 | 12 | ||
| Gender | 0.098 | 0.555 | ||||
| Male | 18 | 46 | 40 | 7 | ||
| Female | 16 | 20 | 26 | 7 | ||
| Location | 0.201 | 0.112 | ||||
| Sinuses | 16 | 41 | 23 | 8 | ||
| Other | 18 | 25 | 20 | 6 | ||
| Lymph node metastasis | 0.032* | 0.461 | ||||
| Positive | 31 | 48 | 53 | 10 | ||
| Negative | 3 | 18 | 13 | 4 | ||
| Positive lymph node ratio | 0.201 | 0.112 | ||||
| ≥ 0.5 | 18 | 25 | 29 | 6 | ||
| <0.5 | 16 | 41 | 37 | 8 | ||
| Tumour infiltration | 0.893 | 0.518 | ||||
| T1 | 2 | 6 | 6 | 0 | ||
| T2 | 2 | 5 | 2 | 3 | ||
| T3 | 23 | 41 | 43 | 10 | ||
| T4 | 6 | 15 | 14 | 2 | ||
| Pathological grading | 0.285 | 0.538 | ||||
| 2 | 4 | 11 | 11 | 2 | ||
| 3 | 24 | 50 | 48 | 9 | ||
| 4 | 6 | 5 | 7 | 3 | ||
| Size | 0.181 | 0.137 | ||||
| ≥ 5 cm | 24 | 35 | 40 | 5 | ||
| <5 cm | 10 | 29 | 26 | 9 | ||
| AJCC staging | 0.189 | 0.676 | ||||
| Stage I | 3 | 7 | 5 | 2 | ||
| Stage II | 9 | 24 | 25 | 4 | ||
| Stage III | 18 | 31 | 30 | 6 | ||
| Stage IV | 4 | 3 | 6 | 1 | ||